Finding the ideal sedative: a non-inferiority study of remimazolam vs propofol in endoscopic retrograde cholangiopancreatography.

Jungnam LeeSeok JeongDon Haeng LeeJin Seok Park

Published in: Journal of gastroenterology and hepatology (2023)

Remimazolam is not inferior to propofol in achieving successful ERCP completion without rescue medication. Incidences of adverse events were comparable. Remimazolam is a safe and effective alternative to propofol for ERCP sedation, expanding options for clinicians and improving patient outcomes.

Keyphrases

ultrasound guided
palliative care
emergency department
intensive care unit
adverse drug
electronic health record